MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
MimedX 表示 FDA 仍不會在 Axiofill 的指定問題上讓步,提起訴訟
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊